FDA alert: Counterfeit version of Botox found in multiple states

April 16, 2024

The products appear to have been purchased from unlicensed sources. Medications purchased from unlicensed sources may be misbranded, adulterated, counterfeit, contaminated, improperly stored and transported, ineffective and/or unsafe.

April 15, 2024: Fake Botox investigation expands to five states; six hospitalized

April 15, 2024

Cases of a botulism-like illness linked to cosmetic injections have been reported in Colorado, Illinois, Kentucky, Tennessee and Washington.

Florida’s final submission: November 2023 documents for its Canadian drug importation program

April 12, 2024

The state of Florida provided these FOIA-responsive documents to PSM for the state’s final and ultimately approved application to establish a Canadian drug importation program.

U.S. officials warn about botulism-like illness linked to counterfeit Botox

April 11, 2024
A vial of fake Botox

People in nine states sought medical treatment and some were hospitalized after receiving injections of fake Botox in what the CDC has characterized as “non-medical settings.”

Alternative funding programs offshore patients and import risks

April 5, 2024

Some employers are “saving money” on health insurance by hiring vendors to broker personal drug importation between their employees and unlicensed, illegal foreign pharmacies. Read more to understand the dangers of this cost-cutting practice.

April 2, 2024: FDA warns against using unapproved, high-dose lidocaine topicals

April 2, 2024
an opaque yellow jar with writing in Korean and English

Numbing creams that exceed the FDA-approved dose can cause irregular heartbeat, seizures and breathing difficulties. CBP has added FDA-regulated products to a pilot program to improve product traceability. Additional domestic and international news about medicine counterfeiting

Like your information on video? Subscribe to our YouTube playlist!

youtube-video-thumbnail

A gang in India sold fake cancer treatments in India, China and the U.S.  Watch.

youtube-video-thumbnail

A Maryland company settled in Gilead Sciences' lawsuit over counterfeit HIV drugs.

Video cover: "Sellers forfeit millions for tianeptine sales" A bottle labelled tianeptine at right.

A supplement company must pay $2.4 million for selling unapproved drugs, including tianeptine, which is banned in 9 states.

Click the images below to see more recent videos.